HORSHAM, Pa., Aug. 02, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. SSKN ("STRATA"), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, will release second quarter financial results on Monday, August 13, after the market close. STRATA Skin Sciences President and Chief Executive Officer, Dr. Dolev Rafaeli, and Matthew C. Hill, Chief Financial Officer, will host a conference call at 4:30 pm Eastern Time to review the Company's progress.
Conference Call Details: | |
Date: | Monday, August 13 |
Time: | 4:30 pm Eastern Time |
Toll Free: | 888-254-3590 |
International: | 323-994-2093 |
Passcode: | 9279759 |
Webcast: | www.strataskinsciences.com |
About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company focused on the therapeutic and aesthetic dermatology market. Its products include the XTRAC® excimer laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions and the STRATAPEN® MicroSystem, marketed specifically for the intended use of micropigmentation.
Investor Contacts: | |
Dolev Rafaeli, Chief Executive Officer | Jeremy Feffer, Managing Director |
STRATA Skin Sciences, Inc. | LifeSci Advisors, LLC |
215-619-3200 | 212-915-2568 |
ir@strataskin.com | Jeremy@LifeSciAdvisors.com |
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.